2015
DOI: 10.1002/pbc.25769
|View full text |Cite
|
Sign up to set email alerts
|

Combined Autoimmune Cytopenias Presenting in Childhood

Abstract: These data suggest that pediatric patients presenting with autoimmune multi-lineage cytopenias should undergo investigation for underlying immune dysregulation, including autoimmune lymphoproliferative syndrome, other primary immunodeficiencies and autoimmune disorders. The development of an international registry for such patients is imperative to improve the understanding of their complex natural history.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
24
1
3

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(30 citation statements)
references
References 30 publications
2
24
1
3
Order By: Relevance
“…More than a half of our children with ES revealed an immune dysregulation (42% PID, 16% rheumatological disease). According to literature, no correlation between etiology or outcome and timing or sequencing of cytopenias presentation was found (5, 25, 26, 30). Serum vitamin B12 level was helpful in the differential diagnosis between IgG low-ALPS and DNT high-CVID (31) in two patients with hypogammaglobulinemia, lymphoproliferation, and raised DNT cell count.…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…More than a half of our children with ES revealed an immune dysregulation (42% PID, 16% rheumatological disease). According to literature, no correlation between etiology or outcome and timing or sequencing of cytopenias presentation was found (5, 25, 26, 30). Serum vitamin B12 level was helpful in the differential diagnosis between IgG low-ALPS and DNT high-CVID (31) in two patients with hypogammaglobulinemia, lymphoproliferation, and raised DNT cell count.…”
Section: Discussionmentioning
confidence: 94%
“…Since 1980 (24), few studies have described the heterogeneity of presenting symptoms and the different underlying etiologies that came to light after an appropriate immune and rheumatological evaluation of children affected by multilineage cytopenias (2, 5, 2426). Our data highlight ES as a possible early manifestation of an underlying immune disorder, PID or rheumatological disease, especially when cytopenias are persistent-resistant to therapy, with an early-onset or when are associated with lymphadenopathy (7, 8, 10, 23, 2629). Particularly, for these patients, a proper laboratory investigation and a careful follow up is necessary to achieve a proper diagnosis.…”
Section: Discussionmentioning
confidence: 99%
“…The current study presents the case of a 7-year-old child who developed ES, an autoimmune multilineage cytopathy, which is characterized by autoimmune hemolytic anemia (AIHA) and immune thrombocytopenic purpura (ITP) [ 7 ]. Though the patient did not have a diagnosable underlying autoimmune disorder such as systemic lupus erythematosus (SLE), the family history was remarkable for SLE, Sjögren syndrome, and Hodgkin lymphoma.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, Al Ghaithi et al. suggested an investigation algorithm for pediatric patients with combined autoimmune cytopenias and immune dysregulation, including autoimmune diseases, such as cSLE . Investigation for cSLE should be done in all ES patients, even in the absence of typical clinical findings such as malar rash and arthritis.…”
Section: Discussionmentioning
confidence: 99%